LAUDER RONALD S 4
4 · ESTEE LAUDER COMPANIES INC · Filed May 5, 2021
Insider Transaction Report
Form 4
LAUDER RONALD S
Chairman, Clinique Labs, LLC10% Owner
Transactions
- Sale
Class A Common Stock
2021-05-05$292.00/sh−1,700,000$496,400,000→ 0 total - Conversion
Class A Common Stock
2021-05-04+1,700,000→ 1,700,000 total - Conversion
Class B Common Stock
2021-05-04−1,700,000→ 5,468,846 total→ Class A Common Stock (1,700,000 underlying)
Holdings
- 6,364(indirect: By Trust)
Class B Common Stock
→ Class A Common Stock (6,364 underlying) - 6,364(indirect: By Trust)
Class A Common Stock
Footnotes (4)
- [F1]Ronald S. Lauder ("RSL") converted shares of Class B Common Stock into an equal number of shares of Class A Common Stock.
- [F2]There is no exercise or conversion price for the Class B Common Stock. Shares of Class B Common Stock (i) may be converted immediately on a one-for-one basis by the holder into shares of Class A Common Stock and (ii) are automatically converted into Class A Common Stock on a one-for-one basis upon transfer to a person or entity that is not a "Permitted Transferee" (as defined in Issuer's Restated Certificate of Incorporation) or soon after a record date for a meeting of stockholders where the outstanding Class B Common Stock constitutes less than 10% of the outstanding shares of Common Stock of the Issuer.
- [F3]Not applicable.
- [F4]RSL disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.